Cite
MLA Citation
Ezra Cohen et al.. “352 Updated clinical data from the squamous cell carcinoma of the head and neck (SCCHN) expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A214–A215. http://access.bl.uk/ark:/81055/vdc_100144718578.0x000006